![Marino Garcia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marino Garcia
Vorstandsvorsitzender bei
DIANTHUS THERAPEUTICS, INC.
Vermögen: 6 Mio $ am 31.05.2026
Profil
Marino Garcia is currently President, Chief Executive Officer & Director at Dianthus Therapeutics OpCo, Inc. since 2021 and holds the same titles at Dianthus Therapeutics, Inc. since 2023.
Former positions include Vice President-Business Development at Aptalis Pharma Canada ULC from 2010 to 2014, Vice President-US Commercial Operations at Aspreva Pharmaceuticals Corp.
from 2006 to 2010, Senior VP-Corporate & Business Development at Zealand Pharma A from 2018 to 2021, and Chief Strategy Officer & Executive Vice President at Synergy Pharmaceuticals LLC from 2016 to 2018.
Education includes an undergraduate degree from Concordia University and an MBA from Richard Ivey School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.03.2026 | 65.292 ( 0,2 % ) | 6 Mio $ | 31.05.2026 |
Aktive Positionen von Marino Garcia
| Unternehmen | Position | Beginn |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Vorstandsvorsitzender | 11.09.2023 |
Dianthus Therapeutics, Inc. (Massachusetts)
 Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Develops therapies for severe autoimmune diseases | Vorstandsvorsitzender | 01.11.2021 |
Ehemalige bekannte Positionen von Marino Garcia
| Unternehmen | Position | Ende |
|---|---|---|
| ZEALAND PHARMA A/S | Corporate Officer/Principal | 01.10.2021 |
| SYNERGY PHARMACEUTICALS INC | Corporate Officer/Principal | 30.09.2018 |
Aptalis Pharma Canada ULC
 Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Corporate Officer/Principal | 13.03.2014 |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.01.2010 |
Ausbildung von Marino Garcia
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
38
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Aptalis Pharma Canada ULC
Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Concordia University
 Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
Richard Ivey School of Business
 Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dianthus Therapeutics, Inc. (Massachusetts)
Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Develops therapies for severe autoimmune diseases | Health Technology |
Dianthus Therapeutics, Inc.
 Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
